| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 37 |
| 1 | ASPIRIN | 34 |
| 2 | ASPIRIN 325 MG | 34 |
| 3 | ASPIRIN 81 MG | 34 |
| 4 | CLOPIDOGREL | 28 |
| 5 | PEMBROLIZUMAB | 27 |
| 6 | ENZALUTAMIDE | 17 |
| 7 | BEVACIZUMAB | 16 |
| 8 | APIXABAN | 15 |
| 9 | BISOPROLOL FUMARATE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUTAMIDE | 11 | 0.0111 |
| 1 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 2 | PANTHENOL | 1 | 0.0034 |
| 3 | TISOTUMAB VEDOTIN | 3 | 0.0031 |
| 4 | RADIUM RA 223 DICHLORIDE | 11 | 0.0022 |
| 5 | FOLLITROPIN ALFA | 4 | 0.0020 |
| 6 | NALDEMEDINE | 3 | 0.0018 |
| 7 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 8 | CHORIOGONADOTROPIN ALFA | 4 | 0.0015 |
| 9 | GANIRELIX ACETATE | 1 | 0.0013 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gonadotropin [EPC] | 4 | 0.0018 |
| 1 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 3 | Antifibrinolytic Agent [EPC] | 5 | 0.0005 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 39 | 0.0004 |
| 8 | Chloride Channel Activator [EPC] | 3 | 0.0003 |
| 9 | Androgen Receptor Inhibitor [EPC] | 19 | 0.0003 |